The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution

The Stupp regimen preceded by early post-surgery temozolomide versus the Stupp regimen alone in the treatment of patients with newly diagnosed glioblastoma multiforme (GBM).

LF Zhou

Consultant or Advisory Role - Merck Sharp & Dohme (U)

Research Funding - Merck Sharp & Dohme

Yu Yao

Consultant or Advisory Role - MSD (U)

Shuyuan Yang

Consultant or Advisory Role - Merck (U)

Xuejun Yang